The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nouri-Shirazi, M.
Right arrow Articles by Palucka, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nouri-Shirazi, M.
Right arrow Articles by Palucka, K. A.
The Journal of Immunology, 2000, 165: 3797-3803.
Copyright © 2000 by The American Association of Immunologists

Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune Responses1

Mahyar Nouri-Shirazi, Jacques Banchereau, Diana Bell, Susan Burkeholder, Elizabeth T. Kraus, Jean Davoust and Karolina A. Palucka2

Baylor Institute for Immunology Research, Dallas, TX 75204

Due to their capacity to induce primary immune responses, dendritic cells (DC) are attractive vectors for immunotherapy of cancer. Yet the targeting of tumor Ags to DC remains a challenge. Here we show that immature human monocyte-derived DC capture various killed tumor cells, including Jurkat T cell lymphoma, malignant melanoma, and prostate carcinoma. DC loaded with killed tumor cells induce MHC class I- and class II-restricted proliferation of autologous CD8+ and CD4+ T cells, demonstrating cross-presentation of tumor cell-derived Ags. Furthermore, tumor-loaded DC elicit expansion of CTL with cytotoxic activity against the tumor cells used for immunization. CTL elicited by DC loaded with the PC3 prostate carcinoma cell bodies kill another prostate carcinoma cell line, DU145, suggesting recognition of shared Ags. Finally, CTL elicited by DC loaded with killed LNCap prostate carcinoma cells, which express prostate specific Ag (PSA), are able to kill PSA peptide-pulsed T2 cells. This demonstrates that induced CTL activity is not only due to alloantigens, and that alloantigens do not prevent the activation of T cells specific for tumor-associated Ags. This approach opens the possibility of using allogeneic tumor cells as a source of tumor Ag for antitumor therapies.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. M. Srivastava, C. Varalakshmi, and A. Khar
The Ischemia-Responsive Protein 94 (Irp94) Activates Dendritic Cells through NK Cell Receptor Protein-2/NK Group 2 Member D (NKR-P2/NKG2D) Leading to Their Maturation
J. Immunol., January 15, 2008; 180(2): 1117 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
R. M. Srivastava, Ch. Varalakshmi, and A. Khar
Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response
Int. Immunol., May 1, 2007; 19(5): 591 - 607.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Bozzacco, C. Trumpfheller, F. P. Siegal, S. Mehandru, M. Markowitz, M. Carrington, M. C. Nussenzweig, A. G. Piperno, and R. M. Steinman
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes
PNAS, January 23, 2007; 104(4): 1289 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Yu. Nikitina, S. A. Desai, X. Zhao, W. Song, A. Z. Luo, R. D. Gangula, K. M. Slawin, and D. M. Spencer
Versatile Prostate Cancer Treatment with Inducible Caspase and Interleukin-12
Cancer Res., May 15, 2005; 65(10): 4309 - 4319.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Groh, Y. Q. Li, D. Cioca, N. N. Hunder, W. Wang, S. R. Riddell, C. Yee, and T. Spies
From The Cover: Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells
PNAS, May 3, 2005; 102(18): 6461 - 6466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Tokunaga, T. Murakami, Y. Endo, M. Nishizaki, S. Kagawa, N. Tanaka, and T. Fujiwara
Human Monocyte-Derived Dendritic Cells Pulsed with Wild-Type p53 Protein Efficiently Induce CTLs against p53 Overexpressing Human Cancer Cells
Clin. Cancer Res., February 1, 2005; 11(3): 1312 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Yuan, J.-B. Latouche, J. L. Reagan, G. Heller, I. Riviere, M. Sadelain, and J. W. Young
Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses
J. Immunol., January 15, 2005; 174(2): 758 - 766.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Driessens, M. Hamdane, V. Cool, T. Velu, and C. Bruyns
Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor
Cancer Res., November 15, 2004; 64(22): 8435 - 8442.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Bonnotte, M. Crittenden, N. Larmonier, M. Gough, and R. G. Vile
MIP-3{alpha} Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity
J. Immunol., October 15, 2004; 173(8): 4929 - 4935.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. M. Thomas, L. M. Santarsiero, E. R. Lutz, T. D. Armstrong, Y.-C. Chen, L.-Q. Huang, D. A. Laheru, M. Goggins, R. H. Hruban, and E. M. Jaffee
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
J. Exp. Med., August 2, 2004; 200(3): 297 - 306.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Yang, J. Addai, W.-h. Tian, A. Frolov, T. M. Wheeler, and T. C. Thompson
Reduced Infiltration of Class A Scavenger Receptor Positive Antigen-Presenting Cells Is Associated with Prostate Cancer Progression
Cancer Res., March 15, 2004; 64(6): 2076 - 2082.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. C. Alaniz, S. Sandall, E. K. Thomas, and C. B. Wilson
Increased Dendritic Cell Numbers Impair Protective Immunity to Intracellular Bacteria Despite Augmenting Antigen-Specific CD8+ T Lymphocyte Responses
J. Immunol., March 15, 2004; 172(6): 3725 - 3735.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. S. Zimmermann, A. Bondanza, A. Monno, P. Rovere-Querini, A. Corti, and A. A. Manfredi
TNF-{alpha} Coupled to Membrane of Apoptotic Cells Favors the Cross-Priming to Melanoma Antigens
J. Immunol., February 15, 2004; 172(4): 2643 - 2650.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Della Bella, S. Nicola, A. Riva, M. Biasin, M. Clerici, and M. L. Villa
Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-{alpha}
J. Leukoc. Biol., January 1, 2004; 75(1): 106 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Zoller
Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host
J. Immunol., December 15, 2003; 171(12): 6941 - 6953.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Mehrotra, R. Stevens, R. Zengou, N. G. Chakraborty, L. H. Butterfield, J. S. Economou, D. I. Dorsky, and B. Mukherji
Regulation of Melanoma Epitope-specific Cytolytic T Lymphocyte Response by Immature and Activated Dendritic Cells, in Vitro
Cancer Res., September 1, 2003; 63(17): 5607 - 5614.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Schlienger, C. S. Chu, E. Y. Woo, P. M. Rivers, A. J. Toll, B. Hudson, M. V. Maus, J. L. Riley, Y. Choi, G. Coukos, et al.
TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients
Clin. Cancer Res., April 1, 2003; 9(4): 1517 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bondanza, V. S. Zimmermann, G. Dell'Antonio, E. Dal Cin, A. Capobianco, M. G. Sabbadini, A. A. Manfredi, and P. Rovere-Querini
Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells
J. Immunol., January 1, 2003; 170(1): 24 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Yu, S. Kusmartsev, F. Cheng, M. Paolini, Y. Nefedova, E. Sotomayor, and D. Gabrilovich
Effective Combination of Chemotherapy and Dendritic Cell Administration for the Treatment of Advanced-Stage Experimental Breast Cancer
Clin. Cancer Res., January 1, 2003; 9(1): 285 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. M. Luhr, R. P. A. Wallin, H.-G. Ljunggren, P. Low, A. Taraboulos, and K. Kristensson
Processing and Degradation of Exogenous Prion Protein by CD11c+ Myeloid Dendritic Cells In Vitro
J. Virol., October 25, 2002; 76(23): 12259 - 12264.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Miller, S. Lahrs, V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo
Adenovirus Infection Enhances Dendritic Cell Immunostimulatory Properties and Induces Natural Killer and T-Cell-mediated Tumor Protection
Cancer Res., September 15, 2002; 62(18): 5260 - 5266.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Tada, J. O-Wang, Y. Takiguchi, K. Tatsumi, T. Kuriyama, S. Okada, T. Tokuhisa, S. Sakiyama, and M. Tagawa
Cutting Edge: A Novel Role for Fas Ligand in Facilitating Antigen Acquisition by Dendritic Cells
J. Immunol., September 1, 2002; 169(5): 2241 - 2245.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Spisek, P. Chevallier, N. Morineau, N. Milpied, H. Avet-Loiseau, J.-L. Harousseau, K. Meflah, and M. Gregoire
Induction of Leukemia-specific Cytotoxic Response by Cross-Presentation of Late-Apoptotic Leukemic Blasts by Autologous Dendritic Cells of Nonleukemic Origin
Cancer Res., May 1, 2002; 62(10): 2861 - 2868.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Masse, C. Voisine, F. Henry, S. Cordel, I. Barbieux, R. Josien, K. Meflah, M. Gregoire, and B. Lieubeau
Increased Vaccination Efficiency with Apoptotic Cells by Silica-induced, Dendritic-like Cells
Cancer Res., February 1, 2002; 62(4): 1050 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. A. Cavacini, M. Duval, J. P. Eder, and M. R. Posner
Evidence of Determinant Spreading in the Antibody Responses to Prostate Cell Surface Antigens in Patients Immunized with Prostate-specific Antigen
Clin. Cancer Res., February 1, 2002; 8(2): 368 - 373.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. M. Dhodapkar, J. Krasovsky, B. Williamson, and M. V. Dhodapkar
Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
J. Exp. Med., January 7, 2002; 195(1): 125 - 133.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. H. Frazer, R. D. Kluyver, G. R. Leggatt, H. Yang Guo, L. Dunn, O. White, C. Harris, A. Liem, and P. Lambert
Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen Exposure
J. Immunol., December 1, 2001; 167(11): 6180 - 6187.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Pietra, R. Mortarini, G. Parmiani, and A. Anichini
Phases of Apoptosis of Melanoma Cells, but not of Normal Melanocytes, Differently Affect Maturation of Myeloid Dendritic Cells
Cancer Res., November 1, 2001; 61(22): 8218 - 8226.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Lapointe, R. E. Royal, M. E. Reeves, I. Altomare, P. F. Robbins, and P. Hwu
Retrovirally Transduced Human Dendritic Cells Can Generate T Cells Recognizing Multiple MHC Class I and Class II Epitopes from the Melanoma Antigen Glycoprotein 100
J. Immunol., October 15, 2001; 167(8): 4758 - 4764.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Meyer zum Buschenfelde, J. Metzger, C. Hermann, N. Nicklisch, C. Peschel, and H. Bernhard
The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells
J. Immunol., August 1, 2001; 167(3): 1712 - 1719.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.